C. Ludlam

发表

TT virus--part of the normal human flora?

P. Simmonds, C. Logue, L. Prescott, 1999, Journal of Infectious Diseases.

Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort

P. Simmonds, J. Parry, C. M. Steel, 1991, The Lancet.

Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates.

P. Simmonds, L. Zhang, C. Ludlam, 1991, AIDS.

Activation of the coagulation cascade in untreated primary open-angle glaucoma.

C. O'brien, C. Ludlam, Z. Butt, 1997, Ophthalmology.

New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation.

C. Ludlam, 1998, Lancet.

Emotional impact of diagnosis and early treatment of lymphomas.

R. Mcguire, C. Ludlam, G. Lloyd, 1984, Journal of psychosomatic research.

Hepatitis C virus genotypes in multi‐transfused individuals

P. Simmonds, C. Ludlam, C. Ludlam, 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

Failure of ADCC to predict HIV‐associated disease progression or outcome in a haemophiliac cohort

J. Habeshaw, A. Dalgleish, C. Ludlam, 1990, Clinical and experimental immunology.

Characterization of a new non-Hodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)].

C. M. Steel, C. Ludlam, D. Saltman, 1988, Blood.

Human Parvovirus B19 and Blood Products

C. Prowse, P. Yap, C. Ludlam, 1997, Vox sanguinis.

Detection of a novel DNA virus (TT virus) in blood donors and blood products

P. Simmonds, D. Macdonald, P. Yap, 1998, The Lancet.

ANTIBODIES TO HEPATITIS C VIRUS IN HAEMOPHILIA

P. Maisonneuve, C. Guérois, Y. Laurian, 1989, The Lancet.

Thrombosis and disseminated intravascular coagulation following treatment with the prothrombin complex concentrate, DEFIX.

C. Ludlam, E. Mayne, P. Roddie, 1999, Thrombosis and haemostasis.

HLA HAPLOTYPE A1 B8 DR3 AS A RISK FACTOR FOR HIV-RELATED DISEASE

P. Simmonds, C. M. Steel, C. Ludlam, 1988, The Lancet.

Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor.

A. J. Stewart, J. Hanley, C. Ludlam, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Recombinant coagulation factors.

C. Ludlam, P. Roddie, 1997, Blood reviews.

An HIV positive haemophiliac with acute lymphoblastic leukaemia successfully treated with intensive chemotherapy and syngeneic bone marrow transplantation.

M. Turner, H. Watson, C. Ludlam, 1992, Bone marrow transplantation.

Treatment of hepatitis C infection in haemophiliacs: the Edinburgh experience

P. Simmonds, J. Hanley, C. Ludlam, 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users

P. Simmonds, L. Zhang, H. Watson, 1990, The Lancet.

Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers

P. Simmonds, P. Balfe, C. Ludlam, 1990, Journal of virology.

Detection of a novel DNA virus (TTV) in blood donors and blood products.

P. Simmonds, L. Jarvis, D. Macdonald, 1998, Lancet.

Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source

P. Simmonds, P. Balfe, C. Ludlam, 2022 .

Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1

P Balfe, P. Simmonds, P. Balfe, 1990 .

Infection with hepatitis G virus among recipients of plasma products

P. Simmonds, P. Yap, F. Davidson, 1996, The Lancet.

Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient.

E. Holmes, P. Simmonds, L. Zhang, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients.

A. Cleland, H. Watson, C. Ludlam, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis

P. Simmonds, L. Zhang, P. Balfe, 1991, Journal of virology.

HEMOPHILIA-A, F8C, DXS15 AND DXS52 - ESTABLISHMENT OF ORDER AND EVIDENCE FOR A FAMILIAL PREDISPOSITION TO CROSSOVER

H. Watson, C. Ludlam, S. Bhattacharya, 1987 .

Guidelines on the diagnosis and management of chronic liver disease in haemophilia

G. Dusheiko, C. Lee, F. Preston, 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia

P. Giangrande, T. Baglin, M. Makris, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

New-variant Creutzfeldt-Jakob disease and treatment of haemophilia

C. Ludlam, 1998, The Lancet.

Platelet and fibrinogen survival in acute promyelocytic leukaemia.

C. Ludlam, A. Parker, M. Bennett, 1976, British medical journal.

Study of viral safety of Scottish National Blood Transfusion Service factor VIII/IX concentrate

G. Lowe, A. Dawson, C. Ludlam, 1993 .

Factor VIII inhibitors in mild and moderate‐severity haemophilia A

R. Bagnall, E. Santagostino, C. Kessler, 1998, Thrombosis and haemostasis.

Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease.

P. Simmonds, M. Makris, F. Preston, 1995, Blood.

Myocardial dysfunction in patients infected with HIV: prevalence and risk factors

R. Brettle, G. Sutherland, N. Boon, 1992, British heart journal.